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Definition {#s0015}
----------

Cardiovascular disease refers to any disease process primarily involving the heart and/or blood vessels.

Synonyms {#s0020}
--------

Cardiovascular disease is being diagnosed more commonly in rabbits. Congestive heart failure, both right- and left-sided, valvular disease, myocardial disease, congenital disease, vascular disease, arteriosclerosis, and atherosclerosis all have been described in the rabbit.

Epidemiology {#s0025}
------------

### Species, Age, Sex {#s0030}

Incidence of acquired cardiovascular disease increases with age.

### Genetics and Breed Predisposition {#s0035}

•Giant breeds are more prone to dilated cardiomyopathy.•Arteriosclerosis has a higher incidence in New Zealand white rabbits and a lower incidence in Dutch rabbits.•Some laboratory strains have been bred with a predisposition to develop atherosclerosis as research models (e.g., Watanabe heritable hyperlipidemic rabbit, St. Thomas\'s Hospital rabbit strain).

### Risk Factors {#s0040}

•Genetics•Dietary factors: cholesterol levels \>0.5%, peanut oil in the diet, high levels of dietary saturated fat, vitamin E deficiency•Chronic stress (e.g., from overcrowding)•Hypertension•Hypercalcemia secondary to hypervitaminosis D or chronic renal insufficiency•Infection with pathogens that may cause cardiovascular disease (e.g., *Pasteurella multocida*, *Staphylococcus* spp., *Salmonella* spp., *Clostridium piriformis*, *Streptococcus viridans*, Coronavirus, and *Encephalitozoon cuniculi* \[see Encephalitozoonosis\])•Doxorubicin has been shown experimentally to cause cardiac disease.•Xylazine anesthesia can induce cardiomyopathy.

### Contagion and Zoonosis {#s0045}

•Very low risk of spread of infectious cardiac disease; cardiovascular lesions develop only occasionally after acute infection•*Salmonella* spp. and *E. cuniculi* have some zoonotic risk.

### Associated Conditions and Disorders {#s0050}

Rabbits recovering from *P. multocida, Salmonella* spp., and *C. piriformis* infections occasionally develop cardiomyopathy.

Clinical Presentation {#s0055}
---------------------

### Disease Forms/Subtypes {#s0060}

Cardiovascular disease can be a life-threatening condition in some rabbits; in others, there may be few or no outward clinical signs.

### History, Chief Complaint {#s0065}

•Weakness•Lethargy•Weight loss (see Anorexia)•Poor exercise tolerance•Dyspnea•Collapsing episodes•Failure to grow•Distended abdomen

### Physical Exam Findings {#s0070}

•Mucosal color revealing cyanosis (assessment difficult in many breeds)•Cold extremities (ear tips and toes)•Increased capillary refill time•Weak and irregular pulse•Tachypnea•Pulmonary crackles and wheezes•Murmur•Arrhythmia•Exophthalmos•Muffled heart sounds•Ascites•Peripheral edema

Not all findings will be present, and some signs such as ascites are rarely seen in rabbits.

Etiology and Pathophysiology {#s0075}
----------------------------

•Coronary arterial circulation is limited; this may predispose rabbits to myocardial ischemia.•Hypercalcemia secondary to hypervitaminosis D or chronic renal insufficiency can lead to mineralization of the aortic arch.
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Differential Diagnosis {#s0085}
----------------------

•Respiratory disease (see Lower Respiratory Tract Disorders)•Thoracic abscess•Thymoma (see Thymoma)•Other thoracic neoplasia

Initial Database {#s0090}
----------------

•Radiography: cardiomegaly is the most common finding; pulmonary edema, plural effusion, and ascites are seen less frequently•Echocardiography: most useful for the diagnosis of cardiac masses, pericardial effusions, and valvular disease, and for differentiation between different forms of cardiomyopathy•Electrocardiography (see Electrocardiography, Sec. II): may be normal in the presence of cardiac disease; most useful for diagnosing arrhythmias; normal sinus rhythm seen in rabbits•Blood pressure measurement: hypertension can occur secondary to noncardiac conditions such as chronic renal insufficiency•Hematology: usually normal•Biochemistry: sometimes normal. In cases of secondary hepatocellular swelling, alkaline phosphatase, aspartate transaminase, and alanine transaminase values may be moderately raised. Prerenal azotemia is seen when glomerular filtration rate is reduced.•Pleural fluid cytologic examination and chemistry•Abdominal fluid cytologic examination and chemistry

Advanced or Confirmatory Testing {#s0095}
--------------------------------

•Doppler echocardiography•Magnetic resonance imaging•Computed tomography
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Therapeutic Goals {#s0105}
-----------------

•Remove underlying cause if possible.•Provide supportive care to minimize clinical signs.•Provide balanced therapeutic therapy to reduce rate of progression of the condition.○To extend and improve the patient\'s quality of life

Acute General Treatment {#s0110}
-----------------------

•Diuretics (e.g., furosemide 1-10 mg/kg q 8-12 h IM, IV to reduce pulmonary edema and/or reduce ventricular end-diastolic volume)•Angiotensin-converting enzyme (ACE) inhibitors (e.g., benazepril 0.25-0.5 mg/kg q 24 h PO)•Coronary vasodilators (e.g., nitroglycerin 2% ointment ≈1 mm/kg applied topically to the inner ear)•Oxygen therapy (delivered via chamber, tent, face mask, or nasal catheter)•Thoracocentesis to remove any significant effusions•Restricted movement•Monitoring of temperature for hypothermia and hyperthermia•Supportive care and treatment of any secondary gastrointestinal hypomotility•Midazolam 0.1-0.2 mg/kg IM to control stress

Chronic Treatment {#s0115}
-----------------

•Benazepril 0.25-0.5 mg/kg q 24 h PO•Furosemide 0.3-4 mg/kg q 8-12 h PO•Pimobendan 0.1-0.3 mg/kg q 12 h PO for its inotropic and vasodilator effects•Digoxin 0.003-0.030 mg/kg q 12-48 h PO (do not use with renal insufficiency)

Drug Interactions {#s0120}
-----------------

Benazepril, furosemide, and pimobendan combinations may have a clinically deleterious hypotensive effect.

Possible Complications {#s0125}
----------------------

Hypotension with combination drug therapy. Occasionally, sole benazepril therapy can have a hypotensive effect.

Recommended Monitoring {#s0130}
----------------------

•Monitor respiration rate and effort, body weight, and blood pressure monthly for the first 4 months. If on benazepril, monitor blood pressure after 3 days or when any deterioration in condition occurs.•Repeat full workup if patient destabilizes.•Perform electrocardiography if arrhythmias are present.•Measure digoxin serum levels after 10 days of therapy. Significant individual variation has been noted. Use 0.5 to 2.0 ng/mL as a guide to therapeutic levels.
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Cardiac disease is rarely cured. It is most commonly managed through a balanced therapeutic approach.
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Comments {#s0145}
--------

Most often, treatment and management of cardiovascular disease in rabbits are extrapolated and modified from canine and feline medicine.

Prevention {#s0150}
----------

•Minimize stress.•Provide an appropriate diet.
